ToxMinds BVBA

ToxMinds BVBA is a Belgium-based scientific consultancy specialising in regulatory toxicology, chemical safety assessment, and environmental risk assessment. The firm supports clients in bringing substances and products to market in compliance with European Union regulations, including the EU Chemicals Regulation (REACH), the Biocidal Products Regulation, and the Cosmetic Products Regulation. Its services span the full spectrum of product safety, from hazard identification and risk characterisation to the preparation of regulatory dossiers and liaison with competent authorities. A defining feature of ToxMinds' offering is its emphasis on New Approach Methodologies (NAMs) to reduce or replace animal testing. The company uses computational modelling tools, such as quantitative structure-activity relationship (QSAR) models, to predict the physico-chemical, toxicokinetic, and hazardous properties of substances. It also provides analogue identification and read-across justification, endocrine disruptor assessment, and environmental risk assessment for medicinal products. The team comprises certified (eco)toxicology consultants and research analysts who monitor developments in regulatory toxicology to deliver state-of-the-art services. ToxMinds serves a diverse set of industry sectors, including industrial chemicals, pharmaceuticals and medical devices, cosmetics and consumer products, and biocides. Its expertise in QSAR modelling and read-across is particularly relevant for REACH registrations, where alternative methods are increasingly accepted for regulatory data submission. The company also assists clients with the environmental risk assessment of human medicinal products, following updated EMA guidance that took effect in September 2024. As a private limited company (BVBA) incorporated in Belgium, ToxMinds operates primarily in the European regulatory landscape but supports clients with global product portfolios. The firm's positioning is that of a specialised, science-driven partner for companies that need to demonstrate the safety of their substances and products without relying on animal testing. Through its consultancy services, ToxMinds helps clients navigate complex regulatory requirements, respond to authority questions, and achieve compliance in a cost-effective and sustainable manner.

ToxMinds BVBA is a private consultancy established in Belgium. While the exact founding date is not publicly documented in the available sources, the company has built a reputation over more than a decade of experience in the pharmaceutical sector, as noted on its website. It has developed expertise in regulatory toxicology and chemical safety, particularly in the context of European Union regulations such as REACH, the Biocidal Products Regulation, and the Cosmetic Products Regulation. The firm's early work likely focused on providing toxicological assessments and regulatory support for industrial chemicals and cosmetics. Over time, ToxMinds expanded its service portfolio to include advanced computational methods, such as QSAR modelling, and read-across justifications, which are increasingly accepted by regulators as alternatives to animal testing. This aligns with the global trend towards New Approach Methodologies (NAMs) in chemical safety assessment. A significant development in the company's history is its involvement in the environmental risk assessment (ERA) of medicinal products. With the updated EMA ERA guidance taking effect on September 1, 2024, ToxMinds positioned itself to help clients navigate the new requirements, offering services such as the preparation of EMA-compliant submissions, literature reviews, and ecotoxicity data evaluation using CRED criteria. ToxMinds has also developed substantial experience in evaluating endocrine disrupting properties of substances, a complex and evolving area of regulatory science. The company's team includes certified (eco)toxicology consultants and research analysts who closely follow scientific and regulatory developments. As a Belgian BVBA, the company operates primarily within the EU but serves clients with global reach. Its growth reflects the increasing demand for specialised regulatory expertise and the shift towards non-animal testing methods in product safety assessment.

• Updated Environmental Risk Assessment (ERA) guidance for medicinal products takes effect; ToxMinds offers services to help clients navigate the changes.

Specialised scientific consultancy using New Approach Methodologies to ensure chemical and product safety without animal testing, with deep expertise in EU regulatory compliance.

• QSAR Modelling

  Computational prediction of toxicity based on chemical structure, using public and commercial tools such as OECD Toolbox, Toxtree, DEREK Nexus, SARAH Nexus, and METEOR Nexus.

• Read-across and analogue justification

  Support for regulatory submissions under REACH, using structural similarity to fill data gaps.

• Endocrine disruptor assessment

  Evaluation of substances for endocrine disrupting properties in humans and the environment.

• Environmental Risk Assessment of Medicinal Products

  Preparation of EMA-compliant submissions, literature reviews, ecotoxicity data evaluation, and testing strategy development for human medicinal products.

1. 1Home - ToxMindstoxminds.com
2. 2Environmental Risk Assessment of Medicinal Products - ToxMindstoxminds.com
3. 3Services - ToxMindstoxminds.com
4. 4QSAR Modelling - ToxMindstoxminds.com
5. 5ToxMinds BVBA - Wikidatawikidata.org